Hero MotoCorp Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:52 pm

Competitors of Hero MotoCorp Ltd

All Competitor Stocks of Hero MotoCorp Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:45 am

Below is a detailed analysis of the quarterly data for Hero MotoCorp Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 9,728.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,970.00 Cr. (Mar 2025) to 9,728.00 Cr., marking a decrease of 242.00 Cr..
• For Expenses, as of Jun 2025, the value is 8,315.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8,529.00 Cr. (Mar 2025) to 8,315.00 Cr., marking a decrease of 214.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 1,413.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,441.00 Cr. (Mar 2025) to 1,413.00 Cr., marking a decrease of 28.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Mar 2025) to 15.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 939.00 Cr.. The value appears strong and on an upward trend. It has increased from 345.00 Cr. (Mar 2025) to 939.00 Cr., marking an increase of 594.00 Cr..
• For Interest, as of Jun 2025, the value is 21.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 206.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 204.00 Cr. (Mar 2025) to 206.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 2,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,565.00 Cr. (Mar 2025) to 2,126.00 Cr., marking an increase of 561.00 Cr..
• For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Mar 2025) to 20.00%, marking a decrease of 5.00%.
• For Net Profit, as of Jun 2025, the value is 1,706.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,169.00 Cr. (Mar 2025) to 1,706.00 Cr., marking an increase of 537.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 85.26. The value appears strong and on an upward trend. It has increased from 58.06 (Mar 2025) to 85.26, marking an increase of 27.20.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:13 am

Growth

Last Updated: September 5, 2025, 6:05 am

Balance Sheet

Last Updated: July 25, 2025, 3:06 pm

Below is a detailed analysis of the balance sheet data for Hero MotoCorp Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 40.00 Cr..
• For Reserves, as of Mar 2025, the value is 19,232.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,659.00 Cr. (Mar 2024) to 19,232.00 Cr., marking an increase of 1,573.00 Cr..
• For Borrowings, as of Mar 2025, the value is 700.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 606.00 Cr. (Mar 2024) to 700.00 Cr., marking an increase of 94.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8,418.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,847.00 Cr. (Mar 2024) to 8,418.00 Cr., marking an increase of 571.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 28,390.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26,153.00 Cr. (Mar 2024) to 28,390.00 Cr., marking an increase of 2,237.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,283.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,232.00 Cr. (Mar 2024) to 6,283.00 Cr., marking an increase of 51.00 Cr..
• For CWIP, as of Mar 2025, the value is 487.00 Cr.. The value appears strong and on an upward trend. It has increased from 484.00 Cr. (Mar 2024) to 487.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 14,384.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,751.00 Cr. (Mar 2024) to 14,384.00 Cr., marking an increase of 1,633.00 Cr..
• For Other Assets, as of Mar 2025, the value is 7,236.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,685.00 Cr. (Mar 2024) to 7,236.00 Cr., marking an increase of 551.00 Cr..
• For Total Assets, as of Mar 2025, the value is 28,390.00 Cr.. The value appears strong and on an upward trend. It has increased from 26,153.00 Cr. (Mar 2024) to 28,390.00 Cr., marking an increase of 2,237.00 Cr..

Notably, the Reserves (19,232.00 Cr.) exceed the Borrowings (700.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Hero MotoCorp Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 218.96. This value is within the healthy range. It has increased from 187.36 (Mar 24) to 218.96, marking an increase of 31.60.
• For Diluted EPS (Rs.), as of Mar 25, the value is 218.96. This value is within the healthy range. It has increased from 187.04 (Mar 24) to 218.96, marking an increase of 31.92.
• For Cash EPS (Rs.), as of Mar 25, the value is 268.08. This value is within the healthy range. It has increased from 231.10 (Mar 24) to 268.08, marking an increase of 36.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 963.60. It has increased from 892.17 (Mar 24) to 963.60, marking an increase of 71.43.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 963.60. It has increased from 892.17 (Mar 24) to 963.60, marking an increase of 71.43.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,046.17. It has increased from 1,890.38 (Mar 24) to 2,046.17, marking an increase of 155.79.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 349.50. This value is within the healthy range. It has increased from 310.36 (Mar 24) to 349.50, marking an increase of 39.14.
• For PBIT / Share (Rs.), as of Mar 25, the value is 308.27. This value is within the healthy range. It has increased from 272.48 (Mar 24) to 308.27, marking an increase of 35.79.
• For PBT / Share (Rs.), as of Mar 25, the value is 304.73. This value is within the healthy range. It has increased from 260.65 (Mar 24) to 304.73, marking an increase of 44.08.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 226.85. This value is within the healthy range. It has increased from 193.22 (Mar 24) to 226.85, marking an increase of 33.63.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 218.92. This value is within the healthy range. It has increased from 187.34 (Mar 24) to 218.92, marking an increase of 31.58.
• For PBDIT Margin (%), as of Mar 25, the value is 17.08. This value is within the healthy range. It has increased from 16.41 (Mar 24) to 17.08, marking an increase of 0.67.
• For PBIT Margin (%), as of Mar 25, the value is 15.06. This value is within the healthy range. It has increased from 14.41 (Mar 24) to 15.06, marking an increase of 0.65.
• For PBT Margin (%), as of Mar 25, the value is 14.89. This value is within the healthy range. It has increased from 13.78 (Mar 24) to 14.89, marking an increase of 1.11.
• For Net Profit Margin (%), as of Mar 25, the value is 11.08. This value exceeds the healthy maximum of 10. It has increased from 10.22 (Mar 24) to 11.08, marking an increase of 0.86.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.69. This value is within the healthy range. It has increased from 9.90 (Mar 24) to 10.69, marking an increase of 0.79.
• For Return on Networth / Equity (%), as of Mar 25, the value is 22.71. This value is within the healthy range. It has increased from 21.15 (Mar 24) to 22.71, marking an increase of 1.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 29.47. This value is within the healthy range. It has increased from 28.51 (Mar 24) to 29.47, marking an increase of 0.96.
• For Return On Assets (%), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.31 (Mar 24) to 15.42, marking an increase of 1.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.50. It has decreased from 1.51 (Mar 24) to 1.50, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.80. This value is within the healthy range. It has increased from 1.46 (Mar 24) to 1.80, marking an increase of 0.34.
• For Quick Ratio (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has increased from 1.21 (Mar 24) to 1.53, marking an increase of 0.32.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 21.71. This value exceeds the healthy maximum of 8. It has increased from 14.14 (Mar 24) to 21.71, marking an increase of 7.57.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 63.94. This value exceeds the healthy maximum of 50. It has decreased from 72.06 (Mar 24) to 63.94, marking a decrease of 8.12.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 53.81. This value exceeds the healthy maximum of 50. It has decreased from 59.94 (Mar 24) to 53.81, marking a decrease of 6.13.
• For Earning Retention Ratio (%), as of Mar 25, the value is 36.06. This value is below the healthy minimum of 40. It has increased from 27.94 (Mar 24) to 36.06, marking an increase of 8.12.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 46.19. This value is within the healthy range. It has increased from 40.06 (Mar 24) to 46.19, marking an increase of 6.13.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 98.94. This value is within the healthy range. It has increased from 81.24 (Mar 24) to 98.94, marking an increase of 17.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 65.22. This value is within the healthy range. It has increased from 53.67 (Mar 24) to 65.22, marking an increase of 11.55.
• For Enterprise Value (Cr.), as of Mar 25, the value is 74,456.73. It has decreased from 94,099.44 (Mar 24) to 74,456.73, marking a decrease of 19,642.71.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 1.82, marking a decrease of 0.67.
• For EV / EBITDA (X), as of Mar 25, the value is 10.65. This value is within the healthy range. It has decreased from 15.17 (Mar 24) to 10.65, marking a decrease of 4.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 2.50 (Mar 24) to 1.82, marking a decrease of 0.68.
• For Retention Ratios (%), as of Mar 25, the value is 36.05. This value is within the healthy range. It has increased from 27.93 (Mar 24) to 36.05, marking an increase of 8.12.
• For Price / BV (X), as of Mar 25, the value is 3.86. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 3.86, marking a decrease of 1.47.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 2.50 (Mar 24) to 1.82, marking a decrease of 0.68.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness